ATON
AlphaTON Capital Corp.NASDAQFinancial Services$0.32-2.65%ClosedMarket Cap: $719,945
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.08
P/S
0.00
EV/EBITDA
-0.03
DCF Value
$1.08
FCF Yield
-506.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-925.1%
ROA
-64.4%
ROIC
-116.3%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $0.00 | $-10.4M | $-4.13 |
| Q1 2026 | $0.00 | $-5.6M | $-2.57 |
| Q4 2025 | $0.00 | $-1.9M | $-0.17 |
| FY 2025 | $0.00 | $-6.8M | $-5.72 |
Trading Activity
Insider Trades
View AllLevitt Wesley Allenofficer
SellWed Mar 18
Company Info
Sector
Financial Services
Industry
—
Country
US
Exchange
NASDAQ
Beta
0.49
AlphaTON Capital Corp. is the rebranded entity formerly known as Portage Biotech Inc., a clinical-stage immuno-oncology company transitioning into a digital asset treasury model focused on accumulating and staking Toncoin (TON). AlphaTON intends to invest significantly in TON tokens, targeting a Long-Term TON treasury of approximately US $100 million.